Amoeba Competitors and Similar CompaniesClear all
Amoeba's competitors and similar companies include Eyenovia.
 Amoeba Amoeba SA is a France-based company that develops, manufactures and markets biological products. |  Eyenovia Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform. | |
Founding Date | Founding Date 2010 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Chassieu, FR HQ Montréal, CA | Locations New York, US HQ |
Employees | Employees 1436% decrease | Employees 22100% increase |
Valuation ($) | Valuation ($) 35.2 m | Valuation ($) 47.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $813.5k (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $303.3k (FY, 2025) |
Gross profit | Gross profit €695k (FY, 2025) | Gross profit $510.2k (FY, 2025) |
Net income | Net income (€8.3m) (FY, 2025) | Net income ($45.3m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Eyenovia
HQ
New York, US
Employees
22
Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform.
View company